Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00050349 |
This study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth of cells that cause metastatic carcinoid and other neuroendocrine tumors.
Condition | Intervention | Phase |
---|---|---|
Carcinoid Neuroendocrine Tumors |
Drug: EPO906 epothilone B |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors |
Estimated Enrollment: | 48 |
Study Start Date: | July 2002 |
Estimated Study Completion Date: | March 2004 |
Ages Eligible for Study: | 18 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Florida | |
H. Lee Moffitt Cancer Center and Research Institute | |
Tampa, Florida, United States | |
United States, Illinois | |
Northwestern/Hematology Oncology Clinic | |
Chicago, Illinois, United States, 60611 | |
United States, Iowa | |
University of Iowa Holden Cancer Center | |
Iowa City, Iowa, United States, 52242 | |
United States, Louisiana | |
Louisiana State University Medical Center | |
New Orleans, Louisiana, United States | |
United States, New York | |
Weill Medical College at Cornell University, Dept. Hem/Onc | |
New York, New York, United States | |
United States, Oregon | |
Oregon Health and Sciences University | |
Portland, Oregon, United States |
Study Chair: | Novartis | Novartis |
Study ID Numbers: | CEPO906A2212 |
Study First Received: | December 4, 2002 |
Last Updated: | August 15, 2006 |
ClinicalTrials.gov Identifier: | NCT00050349 |
Health Authority: | United States: Food and Drug Administration |
Gastrinoma cancer tumor tumour neoplasm carcinoma carcinoid |
neuroendocrine Islet cell VIPoma metastatic intravenous epothilone |
Carcinoid tumor Neuroectodermal Tumors Epothilone B Gastrinoma Epothilones Neoplasms, Germ Cell and Embryonal |
Neuroepithelioma Carcinoid Tumor Adenocarcinoma Neoplasms, Glandular and Epithelial Neuroendocrine Tumors Carcinoma |
Neoplasms Neoplasms by Histologic Type Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Therapeutic Uses |
Mitosis Modulators Tubulin Modulators Neoplasms, Nerve Tissue Antimitotic Agents Pharmacologic Actions |